Major determinants of hyperhomocysteinemia in peritoneal dialysis patients

This publication has 29 references indexed in Scilit:

• Mutation (677 C to T) in the methylenetetrahydrofolate reductase gene aggravates hyperhomocysteinemia in hemodialysis patients
  Kidney International, 1997
• Hyperhomocysteinemia Confers an Independent Increased Risk of Atherosclerosis in End-Stage Renal Disease and Is Closely Linked to Plasma Folate and Pyridoxine Concentrations
  Circulation, 1996
• Homocysteine and Risk of Premature Coronary Heart Disease
  Circulation, 1996
• Folate status is the major determinant of fasting total plasma homocysteine levels in maintenance dialysis patients
  Atherosclerosis, 1996
• Relation Between Folate Status, a Common Mutation in Methylenetetrahydrofolate Reductase, and Plasma Homocysteine Concentrations
  Circulation, 1996
• A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase
  Nature Genetics, 1995
• Hyperhomocysteinemia and traditional cardiovascular disease risk factors in end-stage renal disease patients on dialysis: a case-control study
  Atherosclerosis, 1995
• Determination of free and total homocysteine in human plasma by high-performance liquid chromatography with fluorescence detection
  Journal of Chromatography B: Biomedical Sciences and Applications, 1987
• Accumulation of Sulphur-Containing Amino Acids Including Cysteine-Homocysteine in Patients on Maintenance Haemodialysis
  Clinical Science, 1980
• Plasma amino acid abnormalities in chronic renal failure
  Clinica Chimica Acta; International Journal of Clinical Chemistry, 1972